GlaxoSmithKline: Seizures trials

The registry lists 15 Seizures studies with GlaxoSmithKline as lead sponsor. 0 are open to participants now and 8 have results posted.

Phase 1 1Phase 2 3Phase 3 8Phase 4 2No phase 1(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Dose-Optimization, Adjunctive Treatment Study of Ezogabine/Retigabine Immediate Release in Partial-onset SeizuresTerminatedNCT01721317Phase 4Results posted
• Drug Exposure Registry for GSK2248761, an Investigational NNRTICompletedNCT01458132Results posted
• Study of Retigabine Immediate Release as Adjunctive Therapy to Specified Monotherapy Antiepileptic Treatments in Adults With Partial-Onset SeizuresCompletedNCT01227902Phase 3Results posted
• Open-Label Extension Study of the Phase 3 VRX-RET-E22-302 Double-Blind Trial. 115097TerminatedNCT00310388Phase 3Results posted
• Open-label Extension Study of the Phase 3 VRX-RET-E22-301 Double-Blind TrialCompletedNCT00310375Phase 3Results posted
• Retigabine Efficacy and Safety Trial for Partial Onset Refractory Seizures in EpilepsyCompletedNCT00235755Phase 3Results posted
• Retigabine (Adjunctive Therapy) Efficacy and Safety Study for Partial Onset Refractory Seizures in EpilepsyCompletedNCT00232596Phase 3Results posted
• Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Primary Generalized Tonic-Clonic Seizures (PGTC) SeizuresCompletedNCT00104416Phase 3Results posted
• GW273225 Therapy Added To Current Seizure Treatments In Patients With Partial SeizuresWithdrawnNCT00567424Phase 2
• Patients With Epilepsy Taking LAMICTAL Immediate-Release Who Switch To Extended-Release Formulation And Vice VersaCompletedNCT00264615Phase 3
• LAMICTAL (Lamotrigine) For The Treatment Of Absence SeizuresCompletedNCT00144872Phase 1
• Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial SeizuresCompletedNCT00113165Phase 3
• Pediatric Epilepsy Study in Subjects 1-24 MonthsCompletedNCT00044278Phase 2
• Treatment Of Primary Generalized Tonic-Clonic Seizures With An Investigational New DrugCompletedNCT00043901Phase 4
• Pediatric Epilepsy Trial in Subjects 1-24 MonthsCompletedNCT00043875Phase 2